MFIMFI
AMED

Mesirow Financial Investment Management - Fixed Income’s Amedisys AMED Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-53,530
Closed -$5.63M – 13
2022
Q2 		$5.63M Buy
53,530
+52,355
+4,456% +$6.69M 0.72% 75
2022
Q1 		$202K Buy
1,175
+130
+12% +$19.4K 0.02% 121
2021
Q4 		$169K Buy
+1,045
New +$168K 0.02% 131

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's AMED Position: Q3 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Amedisys (AMED) in Q3 2022, closing a stake of 53,530 shares — an estimated $5.63M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in AMED in Q4 2021 and held it in 3 quarters. The position peaked at $5.63M in Q2 2022. 287 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 53,530 Amedisys shares in Q3 2022, an estimated $5.63M.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Amedisys in Q4 2021 and held it in 3 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Amedisys position peaked at $5.63M in Q2 2022.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2022, filed 8 Nov 2022.